Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 6 | 2021 | 232 | 2.380 |
Why?
|
| Proline | 5 | 2021 | 43 | 1.780 |
Why?
|
| MicroRNAs | 7 | 2021 | 426 | 1.770 |
Why?
|
| HIV-1 | 14 | 2023 | 706 | 1.630 |
Why?
|
| Proline Oxidase | 6 | 2015 | 11 | 1.270 |
Why?
|
| Dipeptidases | 2 | 2023 | 9 | 1.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2019 | 168 | 1.040 |
Why?
|
| Dopamine Uptake Inhibitors | 2 | 2017 | 77 | 1.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2023 | 48 | 0.920 |
Why?
|
| Methamphetamine | 3 | 2021 | 159 | 0.860 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2021 | 65 | 0.850 |
Why?
|
| Adenosine Triphosphate | 3 | 2021 | 196 | 0.840 |
Why?
|
| HIV Infections | 11 | 2023 | 2303 | 0.810 |
Why?
|
| Virus Integration | 7 | 2022 | 58 | 0.740 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2015 | 259 | 0.730 |
Why?
|
| Glutamic Acid | 1 | 2021 | 128 | 0.710 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 82 | 0.710 |
Why?
|
| Homeostasis | 2 | 2021 | 188 | 0.700 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 290 | 0.660 |
Why?
|
| Biotin | 1 | 2018 | 24 | 0.640 |
Why?
|
| Signal Transduction | 3 | 2023 | 1908 | 0.630 |
Why?
|
| Apoptosis | 6 | 2021 | 1398 | 0.610 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 2231 | 0.550 |
Why?
|
| RNA, Messenger | 3 | 2018 | 1207 | 0.530 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2015 | 55 | 0.520 |
Why?
|
| Autophagy | 2 | 2015 | 116 | 0.500 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 85 | 0.480 |
Why?
|
| Protease Inhibitors | 2 | 2003 | 49 | 0.440 |
Why?
|
| Humans | 28 | 2023 | 37093 | 0.430 |
Why?
|
| Neurons | 2 | 2021 | 1175 | 0.420 |
Why?
|
| Virus Replication | 5 | 2021 | 278 | 0.420 |
Why?
|
| DNA, Viral | 5 | 2022 | 304 | 0.420 |
Why?
|
| Mice | 5 | 2023 | 5913 | 0.370 |
Why?
|
| 3' Untranslated Regions | 2 | 2020 | 74 | 0.350 |
Why?
|
| Brain | 1 | 2017 | 1346 | 0.350 |
Why?
|
| Malnutrition | 1 | 2009 | 44 | 0.330 |
Why?
|
| Enzyme Activation | 5 | 2017 | 444 | 0.300 |
Why?
|
| Thiazolidinediones | 2 | 2008 | 50 | 0.280 |
Why?
|
| Chromans | 1 | 2005 | 15 | 0.270 |
Why?
|
| PPAR gamma | 1 | 2005 | 53 | 0.260 |
Why?
|
| Animals | 6 | 2023 | 15081 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2021 | 213 | 0.260 |
Why?
|
| Binding Sites | 3 | 2020 | 651 | 0.250 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2004 | 12 | 0.250 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 61 | 0.240 |
Why?
|
| Collagen | 2 | 2023 | 172 | 0.240 |
Why?
|
| Endopeptidase K | 1 | 2003 | 4 | 0.230 |
Why?
|
| Up-Regulation | 3 | 2015 | 513 | 0.230 |
Why?
|
| Cyclophilin A | 1 | 2023 | 15 | 0.230 |
Why?
|
| Disease Progression | 3 | 2015 | 601 | 0.230 |
Why?
|
| Protein Folding | 1 | 2004 | 127 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2015 | 461 | 0.230 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 93 | 0.220 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 730 | 0.220 |
Why?
|
| Protein Binding | 3 | 2017 | 972 | 0.220 |
Why?
|
| Alkalies | 1 | 2002 | 5 | 0.220 |
Why?
|
| Capsid | 2 | 2020 | 54 | 0.210 |
Why?
|
| Actinobacteria | 1 | 2002 | 9 | 0.210 |
Why?
|
| Histone Code | 1 | 2022 | 13 | 0.210 |
Why?
|
| Nucleosomes | 1 | 2022 | 29 | 0.210 |
Why?
|
| Chromosomes, Human | 1 | 2022 | 35 | 0.210 |
Why?
|
| Mutation | 3 | 2020 | 1095 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 197 | 0.210 |
Why?
|
| HIV Integrase | 2 | 2022 | 20 | 0.200 |
Why?
|
| Exodeoxyribonucleases | 1 | 2021 | 17 | 0.200 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1015 | 0.200 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 67 | 0.190 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2021 | 17 | 0.190 |
Why?
|
| Histones | 1 | 2022 | 190 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 2 | 2023 | 186 | 0.190 |
Why?
|
| Cricetulus | 1 | 2021 | 80 | 0.190 |
Why?
|
| CHO Cells | 1 | 2021 | 124 | 0.190 |
Why?
|
| RNA Interference | 2 | 2021 | 243 | 0.190 |
Why?
|
| Acute Disease | 1 | 2021 | 147 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2021 | 149 | 0.190 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 60 | 0.180 |
Why?
|
| Cell Death | 1 | 2021 | 267 | 0.180 |
Why?
|
| Phosphoproteins | 1 | 2021 | 163 | 0.180 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2020 | 19 | 0.180 |
Why?
|
| Models, Animal | 1 | 2020 | 134 | 0.180 |
Why?
|
| RNA, Viral | 2 | 2019 | 301 | 0.180 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 173 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 540 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 431 | 0.170 |
Why?
|
| Semen | 1 | 2019 | 51 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2019 | 25 | 0.170 |
Why?
|
| Microvessels | 1 | 2019 | 28 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2023 | 681 | 0.160 |
Why?
|
| Proteome | 1 | 2019 | 144 | 0.160 |
Why?
|
| Down-Regulation | 1 | 2020 | 435 | 0.160 |
Why?
|
| Exosomes | 1 | 2019 | 101 | 0.160 |
Why?
|
| Annexin A5 | 1 | 2017 | 26 | 0.150 |
Why?
|
| Cell Nucleus | 4 | 2023 | 366 | 0.150 |
Why?
|
| Indoles | 1 | 2019 | 158 | 0.150 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2017 | 50 | 0.150 |
Why?
|
| Male | 4 | 2021 | 20025 | 0.150 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 78 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 162 | 0.150 |
Why?
|
| Proteomics | 1 | 2019 | 325 | 0.150 |
Why?
|
| Virion | 2 | 2015 | 69 | 0.150 |
Why?
|
| Transfection | 1 | 2018 | 523 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2017 | 129 | 0.140 |
Why?
|
| Cattle | 1 | 2017 | 477 | 0.130 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2015 | 12 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2019 | 308 | 0.130 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 47 | 0.130 |
Why?
|
| Doxycycline | 1 | 2015 | 30 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 807 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 90 | 0.130 |
Why?
|
| Endometrium | 1 | 2015 | 60 | 0.120 |
Why?
|
| Fluoresceins | 2 | 2004 | 27 | 0.120 |
Why?
|
| Cell Line | 4 | 2019 | 1354 | 0.120 |
Why?
|
| Adrenergic Agents | 1 | 2013 | 8 | 0.120 |
Why?
|
| Cell Separation | 1 | 2014 | 93 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 803 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2014 | 399 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1609 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 352 | 0.100 |
Why?
|
| Anti-HIV Agents | 2 | 2019 | 420 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1039 | 0.100 |
Why?
|
| Mitochondria | 1 | 2015 | 487 | 0.100 |
Why?
|
| Dinucleoside Phosphates | 1 | 2011 | 11 | 0.100 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2011 | 33 | 0.100 |
Why?
|
| Capsid Proteins | 2 | 2023 | 67 | 0.100 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2011 | 57 | 0.100 |
Why?
|
| Stress, Physiological | 2 | 2009 | 150 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 63 | 0.100 |
Why?
|
| Virus Latency | 1 | 2010 | 42 | 0.090 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 72 | 0.090 |
Why?
|
| Rats | 1 | 2017 | 3483 | 0.090 |
Why?
|
| Sirolimus | 1 | 2009 | 60 | 0.080 |
Why?
|
| Catalysis | 2 | 2008 | 179 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 433 | 0.080 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2008 | 3 | 0.080 |
Why?
|
| Ligands | 2 | 2008 | 349 | 0.080 |
Why?
|
| Glucose | 1 | 2009 | 230 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.080 |
Why?
|
| Food | 1 | 2008 | 100 | 0.070 |
Why?
|
| Anilides | 1 | 2005 | 28 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 76 | 0.070 |
Why?
|
| Pregnancy | 1 | 2010 | 1549 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 325 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 246 | 0.060 |
Why?
|
| Buffers | 1 | 2004 | 16 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 2004 | 43 | 0.060 |
Why?
|
| Dimerization | 1 | 2004 | 112 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 623 | 0.060 |
Why?
|
| Disulfides | 1 | 2004 | 77 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 441 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 859 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 515 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 208 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 167 | 0.050 |
Why?
|
| Methylation | 1 | 2022 | 113 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2003 | 389 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2023 | 174 | 0.050 |
Why?
|
| Lysine | 1 | 2022 | 113 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2002 | 128 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 708 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 364 | 0.050 |
Why?
|
| Neoplasms | 2 | 2008 | 1103 | 0.050 |
Why?
|
| Chromatin | 1 | 2022 | 169 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 46 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1742 | 0.050 |
Why?
|
| Hela Cells | 1 | 2021 | 366 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 159 | 0.040 |
Why?
|
| Reverse Transcription | 1 | 2019 | 18 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2019 | 115 | 0.040 |
Why?
|
| Young Adult | 2 | 2019 | 4268 | 0.040 |
Why?
|
| Nucleoproteins | 1 | 2017 | 11 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 190 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 602 | 0.040 |
Why?
|
| Monocytes | 1 | 2019 | 257 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2017 | 143 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2017 | 109 | 0.030 |
Why?
|
| Metrorrhagia | 1 | 2015 | 7 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1371 | 0.030 |
Why?
|
| Female | 2 | 2015 | 20969 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Proviruses | 1 | 2015 | 29 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 227 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 677 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 113 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 236 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 10129 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 312 | 0.030 |
Why?
|
| Adult | 2 | 2019 | 11712 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1518 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 492 | 0.020 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2008 | 1 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2008 | 32 | 0.020 |
Why?
|
| PPAR delta | 1 | 2008 | 3 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 30 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2008 | 100 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2008 | 84 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 207 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 5363 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 618 | 0.010 |
Why?
|